Novozymes releases its 2015 second quarter and first-half results, revising sales growth expectations. Total sales in the first half of 2015 increased by 5 percent organically compared with the first half of 2014.
“First-half earnings have been very satisfactory, but we need to increase growth,” says Peder Holk Nielsen, president and CEO of Novozymes’ global operations. “Good developments in other areas such as agriculture & feed and food & beverages balance things out, but don’t make up for the headwinds. We therefore reduce our sales growth expectations for the full year. We maintain our full-year profit outlook, as we see improved productivity and operational efficiencies leading to a higher EBIT margin.”
More information is available here: http://www.novozymes.com/en/investor/news-and-announcements/Documents/2015_37_Q22015_CompanyAnnouncement_EN_FINAL.pdf
More information is available here: http://www.novozymes.com/en/investor/news-and-announcements/Documents/2015_37_Q22015_CompanyAnnouncement_EN_FINAL.pdf
